One Specific Blood Protein Can Identify Dementia Risk Decades Before Diagnosis
A specific blood protein may enable early detection of dementia risk, decades before symptoms appear.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Research indicates that a particular blood protein can identify dementia risk long before diagnosis. Coverage from UAB Barcelona, Ad-hoc-news.de, Medical Daily, Nature, and ScienceAlert emphasizes the potential for early detection.
The Elecsys pTau 217 blood test from Roche Holding AG has received CE marking, moving Alzheimer’s diagnosis to plasma. The FDA has approved new blood tests for early detection, but access remains limited.
Watch for developments in the availability and accessibility of these diagnostic tools. Coverage does not yet specify how soon the Elecsys pTau 217 blood test will be available in the US.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 1h ago.
Quick answers
What is the significance of the Elecsys pTau 217 blood test?
The Elecsys pTau 217 blood test from Roche Holding AG has received CE marking, allowing for Alzheimer’s diagnosis through plasma analysis.
How early can dementia risk be detected with this new method?
According to coverage from ScienceAlert, one specific blood protein can identify dementia risk decades before diagnosis.
What challenges are associated with the new blood tests for Alzheimer's?
According to Medical Daily, while new FDA-approved blood tests can detect Alzheimer's before symptoms worsen, access remains limited.
Coverage (5)
- Detecting Alzheimer's disease in its early stages could be possible UAB Barcelona · 1d ago
- Elecsys pTau 217 blood test from Roche Holding AG - CE-marked Alzheimer’s diagnosis moves to plasm Ad-hoc-news.de · 1d ago
- New FDA-Approved Blood Tests Can Detect Alzheimer's Before Symptoms Worsen, but Access Remains Limited Medical Daily · 1d ago
- SECmeres outperform extracellular vesicles as potential blood RNA biomarkers for Alzheimer’s disease Nature · 1d ago
- One Specific Blood Protein Can Identify Dementia Risk Decades Before Diagnosis ScienceAlert · 1d ago
Topics
Related trends
An 80-year-old woman with advanced Alzheimer's regained speech and mobility after taking psilocybin
An 80-year-old woman with Alzheimer's has regained speech and mobility after taking psilocybin.
These Beloved Snacks Are Linked To An Increased Dementia Risk. Here's What Doctors Want You To Know.
New research highlights a connection between specific dietary choices, including popular snacks, and an increased risk of dementia.
This disease is more expensive than cancer and heart disease combined. And it’s only going to get worse.
The cost of dementia care in the U.S. is projected to reach $818 billion in 2026, surpassing the combined costs of cancer and heart disease.
Can wiggling your pinky really stop cognitive decline?
A viral hand exercise involving the pinky finger is trending as a purported method to test for or prevent cognitive decline and Alzheimer's.
WHO urges scale up of newborn screening to improve early detection and care of birth defects
The World Health Organization is pushing for expanded newborn screening to detect birth defects early.
A blood test that screens for multiple types of cancer? It may be available soon
A blood test that can screen for multiple cancers is nearing real-world use, sparking hope and investment interest.